Literature DB >> 214805

Clinical, neuropathologic and pharmacologic aspects of Huntington's disease: correlates with a new animal model.

J T Coyle, R Schwarcz, J P Bennett, P Campochiaro.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 214805     DOI: 10.1016/0364-7722(77)90025-x

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol        ISSN: 0364-7722


× No keyword cloud information.
  11 in total

1.  ATP as a marker of excitotoxin-induced nerve cell death in vivo.

Authors:  A Vezzani; L Sangalli; H Q Wu; R Schwarcz
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

2.  Ontogenetic development of kainate neurotoxicity: correlates with glutamatergic innervation.

Authors:  P Campochiaro; J T Coyle
Journal:  Proc Natl Acad Sci U S A       Date:  1978-04       Impact factor: 11.205

3.  Effects of amphetamine and apomorphine on locomotor activity after kainic acid lesion of the nucleus accumbens septi in the rat.

Authors:  E Kafetzopoulos
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

4.  Quinolinic acid phosphoribosyltransferase: preferential glial localization in the rat brain visualized by immunocytochemistry.

Authors:  C Köhler; E Okuno; P R Flood; R Schwarcz
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

5.  GABAergic and glycinergic mechanisms within the substantia nigra: pharmacological specificity of dopamine-independent contralateral turning behavior and interactions with other neurotransmitters.

Authors:  J Arnt; J Scheel-Krüger
Journal:  Psychopharmacology (Berl)       Date:  1979-04-25       Impact factor: 4.530

6.  Some factors influencing the neurotoxicity of intrastriatal injections of kainic acid.

Authors:  E G McGeer; P L McGeer
Journal:  Neurochem Res       Date:  1978-08       Impact factor: 3.996

7.  Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine.

Authors:  G R Breese; A A Baumeister; T J McCown; S G Emerick; G D Frye; K Crotty; R A Mueller
Journal:  J Pharmacol Exp Ther       Date:  1984-11       Impact factor: 4.030

8.  Quinolinate-like neurotoxicity produced by aminooxyacetic acid in rat striatum.

Authors:  W A Turski; E Urbańska; M Sieklucka; C Ikonomidou
Journal:  Amino Acids       Date:  1992-10       Impact factor: 3.520

Review 9.  Of mice, rats and men: Revisiting the quinolinic acid hypothesis of Huntington's disease.

Authors:  Robert Schwarcz; Paolo Guidetti; Korrapati V Sathyasaikumar; Paul J Muchowski
Journal:  Prog Neurobiol       Date:  2009-04-24       Impact factor: 11.685

10.  Graft-induced behavioral recovery in an animal model of Huntington disease.

Authors:  O Isacson; S B Dunnett; A Björklund
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.